The VOLABIOS Living Lab
The VOLABIOS Living Lab is a virtual, Europe-wide collaborative space designed to bring together individuals affected by schizophrenia, healthcare professionals, researchers, developers, and policymakers. It fosters open innovation and continuous feedback to refine and co-design tools and methodologies for better understanding, diagnosing, and managing schizophrenia (SZ).
Our Living Lab isn’t just a platform—it’s a movement toward inclusive, patient-centered care. It is structured around a quadruple-helix model, engaging academia, industry, government, and civil society, with special attention to diversity, gender equality, and inclusivity.
Living Lab Objectives
Facilitate End-User Engagement: Through participatory activities like hackathons and collaborative workshops, we capture insights and ideas from real users, including patients, caregivers, and clinicians.
Support Solution Co-Creation: Participants contribute directly to the development of AI-powered diagnostic tools, mobile health applications, and data-sharing strategies.
Drive Innovation: The lab acts as a testbed for emerging technologies related to VOC (volatile organic compounds) detection and multi-omics data analysis in SZ.
Strengthen Community and Trust: Building a supportive community that fosters dialogue, reduces stigma, and increases public awareness of SZ and its scientific underpinnings.

HOURS & PRICING
We look forward to seeing you!

Key Activities
Online Hackathons: Targeting students and early-career professionals to propose tech solutions for SZ challenges, with non-monetary awards and mentoring opportunities.
Virtual Platform Development: A GDPR-compliant open API-enabled platform for sharing anonymized data, discussing ideas, and iterating product designs.
Technical Meetings: Regular cross-sector meetings ensure validation processes remain robust and adaptable across various user groups and geographical contexts.
Community Building: Establishment of an online social hub to enable ongoing discussions and connections between all stakeholders.
This approach ensures that real-world needs shape the direction of the VOLABIOS toolkit, from data collection protocols to decision support systems. By doing so, the Living Lab helps bridge the gap between cutting-edge science and actual patient benefit, empowering users while enhancing scientific validity and societal impact.
750
CLIENTS
400
OUR CLIENTS
250
MEMBERS
Our Methodology
Multi-Omics Analysis
Volatolomics
Artificial Intelligence
Research Phases



Retrospective Analysis
Examination of 9 million medical records, including 120,000 related to schizophrenia.
Clinical Research
Monitoring 3,692 patients across six European medical centers for 18-36 months to
validate findings.
Blind Study
Evaluation of biomarkers with 1,000 participants to confirm accuracy and efficacy.
WHAT SPEAK PEOPLE

“I greatly appreciate the communication on the very hard process, what we needed to do in terms of providing good samples, what to expect. Novalab laboratory provided tests what we needed in terms of laboratory certification that we can use with our customers.”
Victoria Porter
CEO at Google INC
“I greatly appreciate the communication on the very hard process, what we needed to do in terms of providing good samples, what to expect. Novalab laboratory provided tests what we needed in terms of laboratory certification that we can use with our customers.”
Maria Flynn
CEO at Google INC
“I greatly appreciate the communication on the very hard process, what we needed to do in terms of providing good samples, what to expect. Novalab laboratory provided tests what we needed in terms of laboratory certification that we can use with our customers.”
Gina Kennedy
CEO at Google INCThe impact
VOLABIOS aims to transform schizophrenia care by improving early detection and intervention through innovative, non-invasive diagnostics. This will reduce the socioeconomic burden of the disease and empower clinicians with advanced tools and data. By setting new standards in mental health care, the project will create a positive global impact, inspiring progress in precision medicine and better patient outcomes.

HOURS & PRICING
We look forward to seeing you!
The jury members

Professor name
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Professor name
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Professor name
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.